Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane

References

• Farrand KF, Fridman M, Stillman I, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90–98. doi:10.1016/j.ajo.2017.06.033
   PubMed Web of Science ®Google Scholar
• Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Surv Ophthalmol. 2020;65:205–217. doi:10.1016/j.survophthal.2019.08.007
   PubMed Web of Science ®Google Scholar
• Mead OG, Tighe S, Tseng SCG. Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis. Taiwan J Ophthalmol. 2020;10:13–21. doi:10.4103/tjo.tjo_5_20
   PubMedGoogle Scholar
• Tighe S, Mead OG, Lee A, Tseng SCG. Basic science review of birth tissue uses in ophthalmology. Taiwan J Ophthalmol. 2020;10:3–12. doi:10.4103/tjo.tjo_4_20
   PubMedGoogle Scholar
• McDonald MB, Sheha H, Tighe S, et al. Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. Clin Ophthalmol. 2018;9:677–681. doi:10.2147/OPTH.S162203
   Google Scholar
• John T, Tighe S, Sheha H, et al. Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease. J Ophthalmol. 2017;2017:10. doi:10.1155/2017/6404918
   Web of Science ®Google Scholar
• Cheng AM, Zhao D, Chen R, et al. Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane. Ocul Surf. 2016;14:56–63. doi:10.1016/j.jtos.2015.07.003
   PubMed Web of Science ®Google Scholar
• Sheppard J, Yeu E, Tseng S. Sutureless Cryopreserved Amniotic Membrane Transplantation Accelerates Ocular Surface Healing and Topographic Stabilization for Dry Eye Patients. NJ, USA: Wiley-Blackwell; 2015.
   Google Scholar
• Vendal Z. Management of glaucoma medication induced dry eye disease with self-retained cryopreserved amniotic membrane. J Dry Eye Dis. 2022;5:e28–e34. doi:10.22374/jded.v5i1.41
   Google Scholar
• Suri K, Kosker M, Raber IM, et al. Sutureless amniotic membrane ProKera for ocular surface disorders: short-term results. Eye Contact Lens. 2013;39:341–347. doi:10.1097/ICL.0b013e3182a2f8fa
   PubMed Web of Science ®Google Scholar
• Lemp MA, Foulks GN. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:75–92. doi:10.1016/S1542-0124(12)70081-2
   PubMed Web of Science ®Google Scholar
• Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130:90–100. doi:10.1001/archophthalmol.2011.364
   PubMed Web of Science ®Google Scholar
• Holland EJ, Luchs J, Karpecki PM, et al. Lifitegrast for the treatment of dry eye disease: results of a Phase III, randomized, double-masked, placebo-controlled trial (OPUS-3). Ophthalmology. 2017;124:53–60. doi:10.1016/j.ophtha.2016.09.025
   PubMed Web of Science ®Google Scholar
• Sheppard JD, Torkildsen GL, Lonsdale JD, et al. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 Phase 3 study. Ophthalmology. 2014;121:475–483. doi:10.1016/j.ophtha.2013.09.015
   PubMed Web of Science ®Google Scholar
• Tepelus TC, Chiu GB, Huang J, et al. Correlation between corneal innervation and inflammation evaluated with confocal microscopy and symptomatology in patients with dry eye syndromes: a preliminary study. Graefes Arch Clin Exp Ophthalmol. 2017;255:1771–1778. doi:10.1007/s00417-017-3680-3
   PubMed Web of Science ®Google Scholar
• Okada Y, Sumioka T, Ichikawa K, et al. Sensory nerve supports epithelial stem cell function in healing of corneal epithelium in mice: the role of trigeminal nerve transient receptor potential vanilloid 4. Lab Invest. 2019;99:210–230. doi:10.1038/s41374-018-0118-4
   PubMed Web of Science ®Google Scholar
• Shi X, Wang L, Clark JD, Kingery WS. Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways. Regul Pept. 2013;186:92–103. doi:10.1016/j.regpep.2013.08.001
   PubMedGoogle Scholar
• Yang L, Di G, Qi X, et al. Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor. Diabetes. 2014;63:4262–4274. doi:10.2337/db14-0163
   PubMed Web of Science ®Google Scholar
• Arif FAC, Hilmi MR, Kamal KM. A prospective contralateral eye comparison of the tolerability of two artificial tears with different physical properties in patients with dry eye disease. Med Hypothesis Discov Innov. 2023;4:1–6. doi:10.51329/mehdioptometry167
   Google Scholar
• Che Arif F, Hilmi MR, Kamal K, Ithnin M. Comparison of immediate effects on usage of dual polymer artificial tears on changes in tear film characteristics. IIUM Med J Malays. 2020;2020:18.
   Google Scholar
• Kheirkhah A, Dohlman TH, Amparo F, et al. Effects of corneal nerve density on the response to treatment in dry eye disease. Ophthalmology. 2015;122:662–668. doi:10.1016/j.ophtha.2014.11.006
   PubMed Web of Science ®Google Scholar
• He H, Li W, Tseng DY, et al. Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane. J Biol Chem. 2009;284:20136–20146. doi:10.1074/jbc.M109.021881
   PubMed Web of Science ®Google Scholar
• He H, Tan Y, Duffort S, Perez VL, Tseng SC. In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane. Invest Ophthalmol Vis Sci. 2014;55:1647–1656. doi:10.1167/iovs.13-13094
   PubMed Web of Science ®Google Scholar
• He H, Li W, Chen SY, et al. Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract. Invest Ophthalmol Vis Sci. 2008;49:4468–4475. doi:10.1167/iovs.08-1781
   PubMed Web of Science ®Google Scholar
• He H, Zhang S, Tighe S, Son J, Tseng SC. Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotype. J Biol Chem. 2013;288:25792–25803. doi:10.1074/jbc.M113.479584
   PubMed Web of Science ®Google Scholar
• He H, Kuriyan AE, C-W S, et al. Inhibition of proliferation and epithelial mesenchymal transition in retinal pigment epithelial cells by heavy chain-hyaluronan/pentraxin 3. Sci Rep. 2017;7:43736. doi:10.1038/srep43736
   PubMed Web of Science ®Google Scholar
• Tighe S, Moein H-R, Chua L, Cheng A, Hamrah P, Tseng SCG. Topical cryopreserved amniotic membrane and umbilical cord eye drops promote re-epithelialization in a murine corneal abrasion ModelAMUC for promoting re-epithelialization. Invest Ophthalmol Vis Sci. 2017;58:1586–1593. doi:10.1167/iovs.16-20834
   PubMed Web of Science ®Google Scholar